bio stocks
Scope
Date
~
-
Mergers & Acquisitions
Qoo10 to buy another Korean rival for unit’s Nasdaq listing
Southeast Asia-based e-commerce platform Qoo10 Pte. Ltd. is poised to take over a smaller South Korean rival through a stock swap deal, in a bid to ...
Mar 14, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
CGBio opens cosmetic surgery clinic in Bali using bio-medical tech
CGBio, a South Korean bio-renewable medical company, announced on Monday that it opened a medical esthetic clinic, called Nulook, in Bali, Indonesia...
Mar 14, 2023 (Gmt+09:00)
-
Korean stock market
Foreign investors net buyers of Korean stocks for 5th straight month
Foreign investors bought more South Korean stocks in February, extending their buying spree to five months.The Financial Supervisory Service of Kore...
Mar 09, 2023 (Gmt+09:00)
-
Companies
CJ CheilJedang opens internal venture development space Inno Play
South Korea's food and bio giant CJ CheilJedang Corp. on Sunday said it opened Inno Play, an office space for commercializing innovative ideas and d...
Mar 06, 2023 (Gmt+09:00)
-
Shareholder activism
KT&G’s hidden saviors in activist fight: In-house funds
KT&G Corp., the world’s fifth-largest tobacco maker, will likely get support from in-house shareholders in a battle against activist funds...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Pension funds
S.Korea's NPS likely to log 8.2% loss for 2022, record-low return
South Korea’s National Pension Service (NPS) is expected to post a negative return of 8.2% for 2022, according to its preliminary report on Th...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
CJ CheilJedang invests in Australian bio startup
South Korea's food and bio company CJ CheilJedang Corp. on Wednesday said it will invest in the Australian bio startup Provectus Algae.The former se...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Korean stock market
S.Korean firms with focus on emerging Asia to shine
South Korean companies with a large proportion of sales to emerging Asia are expected to shine in the stock market this year as their revenue from t...
Feb 24, 2023 (Gmt+09:00)
-
Shareholder activism
KT&G potential target of aggressive activist shareholder
KT&G Corp., the world’s fifth-largest tobacco maker, is likely to face a tougher battle against activist shareholders as an aggressive hed...
Feb 22, 2023 (Gmt+09:00)
-
Batteries
Will CATL’s bargain sales hurt Korean EV battery makers?
China’s Contemporary Amperex Technology Co. (CATL), the leading global electric vehicle battery manufacturer, has started a price war in the w...
Feb 21, 2023 (Gmt+09:00)
-
Korean stock market
Stock inflows to Korea slow on weak currency, valuation
A weaker South Korean currency and worries about valuation have deterred foreign investors’ appetite for local shares, casting expectations of...
Feb 20, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
HYBE not to raise tender offer price for SM Entertainment
HYBE Co., the label behind the world’s top boyband BTS, said it does not plan to raise its buying price for SM Entertainment Co., denting hope...
Feb 20, 2023 (Gmt+09:00)
-
Real estate
Korea's Cha Bio Group to expand overseas real estate business
Cha Bio Group, consisting of Cha Biotech and Cha Vaccine Research Institute as its subsidiaries, has announced its expansion into the real estate in...
Feb 17, 2023 (Gmt+09:00)
-
Korean stock market
Samsung C&T to cancel $2.3 bn worth of treasury shares, stocks up
Samsung C&T Corp.’s share price zoomed on Thursday on news that the company will cancel its entire treasury stock holdings worth about 2.9...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
EOFlow's insulin injection pump starts to be sold in UAE
South Korea's medical device maker EOFlow Co. started selling the wearable insulin pump EOPatch in the United Arab Emirates.The company said on Tues...
Feb 15, 2023 (Gmt+09:00)
-
Korean stock market
KB Securities launches AI-based RoboNews on US stocks
South Korea's KB Securities announced the launch of KB RoboNews on Monday, a cutting-edge artificial intelligence (AI) service that provides insight...
Feb 14, 2023 (Gmt+09:00)
-
Korean stock market
Individual investors in S.Korea betting on stock market's decline
Despite South Korea's Kosdaq stock market growing this month following the "January rally," individual investors in the country are still betting on...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's Herceptin biosimilar proves equivalence in clinical trials
Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...
Feb 08, 2023 (Gmt+09:00)
-
Regulations
Korea seeks legal system for independent equity research firms
South Korea is set to establish a legal system for independent equity research providers this year to protect individual investors, who could be dam...
Feb 08, 2023 (Gmt+09:00)
-
Korean stock market
Korea Shipbuilding & Offshore Engineering ends fears over stock overhang
Korea Shipbuilding & Offshore Engineering (KSOE), a subholding company for shipbuilding, oil refining and machinery conglomerate HD Hyundai Co. ...
Feb 03, 2023 (Gmt+09:00)
-
IPOs
S.Korea's online K Bank withdraws plan for Kospi listing
South Korea's K Bank has withdrawn its highly anticipated plan to hold an IPO this year in the judgement of a lower corporate value due to the slugg...
Feb 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
UK's Croda to buy Korean bio materials maker for $286 mn
Croda International Plc., a British specialty chemicals company, is set to acquire South Korean bio materials producer Solus Biotech Co. for some 35...
Feb 02, 2023 (Gmt+09:00)
-
Venture capital
Korea's venture capital investment falls 12% last year amid downturn
South Korea's venture capital investment last year fell more than 10% from a year ago due to the economic downturn caused by a series of global rate...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Hancom Carelink invests in bio big data venture 3bigs
South Korea's Hancom Carelink, a digital health care company under Hancom Group, on Wednesday said it bought an unspecified stake in the bio big dat...
Jan 26, 2023 (Gmt+09:00)
-
Pension funds
Bank's retirement pension soars 15% to $107 bn last year
Retirement pensions at banks in the fourth quarter of last year emerged as a haven for money that tried to generate a stable return, shunning away f...
Jan 25, 2023 (Gmt+09:00)
-
Korean stock market
S.Korean stock issuance volume declines 24% in 2022
The volume of stock issuance in South Korea declined sharply last year due to the softening stock market. Amid rising interest rates, the amount of ...
Jan 25, 2023 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet